Impact of Obesity on Plasma Natriuretic Peptide Levels

Wang, Thomas J., Larson, Martin G., Levy, Daniel, Benjamin, Emelia J., Leip, Eric P., Wilson, Peter W.F., Vasan, Ramachandran S.·2004·Circulation
DOI 10.1161/01.cir.0000112582.16683.ea

Cited by (1,000)

Items 501–600 of 1,000

  1. Acute effects of insulin on circulating natriuretic peptide levels in humans
    Katherine N. Bachmann, Serpil Müge Değer, Aseel Alsouqi, Shi Huang, Meng Jiao Xu, Jane F. Ferguson, Yan Ru Su, Kevin Dean Niswender, Talat Alp Ikizler, Thomas J. Wang · 2018 · PLoS ONE
  2. Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes
    Marie Louise Johansen, Morten Schou, Jon Rasmussen, Patrick Rossignol, Maria Refsgaard Holm, Elizaveta Chabanova, Flemming Dela, Jens Oscar Faber, Caroline Kistorp · 2018 · Diabetes & Metabolism
  3. Metabolic Crosstalk between the Heart and Fat
    Kimberly M. Ferrero, Walter J. Koch · 2020 · Korean Circulation Journal
  4. Natriuretic peptides and neprilysin inhibition in hypertension and hypertensive organ damage
    Johji Kato · 2020 · Peptides
  5. C-type natriuretic peptide plasma levels are reduced in obese adolescents
    Silvia Del Ry, Manuela Cabiati, V. Bianchi, Simona Storti, Chiara Caselli, Tommaso Prescimone, Aldo Clerico, Giuseppe Saggese, Daniela Giannessi, Giovanni Federico · 2013 · Peptides
  6. Emergency Department Perspectives on B‐Type Natriuretic Peptide Utility
    W. Frank Peacock, Christian Eugen Mueller, Salvatore DiSomma, Alan S. Maisel · 2008 · Congestive Heart Failure
  7. The association of brain natriuretic peptide and insulin resistance in obesity-related hypertension
    Selda Tekeş Serbest, Ayşe Sertkaya Çıkım · 2007 · Journal of Human Hypertension
  8. Optimizing Treatment and Outcomes in Acute Heart Failure: Beyond Initial Triage
    Marc A. Silver, William Franklin Peacock, Deborah B. Diercks · 2006 · Congestive Heart Failure
  9. Usefulness of B-Type Natriuretic Peptide Levels to Predict Left Ventricular Filling Pressures in Patients With Body Mass Index >35, 31 to 35, and ≤30 kg/m2
    Hisham Dokainish, Rafael Gonzalez, W. Bryan Hartley, Angel Eduardo Caldera, Santhosh K. G. Koshy, Ranjita Sengupta, Nasser M. Lakkis · 2007 · The American Journal of Cardiology
  10. Dynamic left ventricular dyssynchrony contributes to B-type natriuretic peptide release during exercise in patients with systolic heart failure
    Patrizzio Lancellotti, Bernard Cosyns, Luc Piérard · 2008 · EP Europace
  11. Plasma Brain Natriuretic Peptide and N-Terminal Proatrial Natriuretic Peptide Levels in Obese Patients: A Cause or Result of Hypertension?
    Junichi Minami, Toshio Nishikimi, Hiroaki Matsuoka · 2004 · Circulation
  12. Obese Hypertensive Men Have Lower Circulating Proatrial Natriuretic Peptide Concentrations Despite Greater Left Atrial Size
    Asferg, Camilla L, Andersen, Ulrik B, Linneberg, Allan, Goetze, Jens P, Jeppesen, Jørgen L · 2018 · American Journal of Hypertension
  13. Effect of Bariatric Surgery on Natriuretic Peptide Levels
    Sama Anvari, Yung Lee, Megan Lam, Jorge A. Wong, Dennis Hong, Aristithes G. Doumouras · 2020 · Cardiology in Review
  14. Underweight Is Associated with Poor Prognosis in Heart Failure with Preserved Ejection Fraction
    Yutaka Matsuhiro, Masami Nishino, Kohei Ukita, Akito Kawamura, Hitoshi Nakamura, Koji Yasumoto, Masaki Tsuda, Naotaka Okamoto, Akihiro Tanaka, Yasuharu Matsunaga‐Lee et al. · 2021 · International Heart Journal
  15. Loss of atrial natriuretic peptide signaling causes insulin resistance, mitochondrial dysfunction, and low endurance capacity
    Deborah Carper, Marlène Lac, Marine Coué, Axel Labour, André Märtens, Jorge Alberto Ayala Banda, Laurène Mazeyrie, Mie Mechta, Lars Roed Ingerslev, Mohamed A. Elhadad et al. · 2024 · Science Advances
  16. Usefulness of Plasma BNP Levels as a Marker of Left Ventricular Wall Stress in Obese Individuals
    Shinya Tosa, Hiroyuki Watanabe, Kenji Iino, Gen Terui, Toshimitsu Kosaka, Hitoshi Hasegawa, Hiroshi Ito · 2009 · International Heart Journal
  17. Low Serum Long-acting Natriuretic Peptide Level Correlates with Metabolic Syndrome in Hypertensive Patients: A Cross-sectional Study
    Jen‐Che Hsieh, Ji‐Hung Wang, Chung‐Jen Lee, Yu‐Chih Chen, Hung‐Hsiang Liou, Bang‐Gee Hsu · 2013 · Archives of Medical Research
  18. N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study
    Erika Jones, Janet Wei, Michael Douglas Nelson, May Bakir, Puja K. Mehta, CHRISANDRA L. SHUFELT, Margo Minissian, Behzad Sharif, Carl J. Pepine, Eileen Mary Handberg et al. · 2020 · PLoS ONE
  19. Natriuretic Peptide Deficiency in Obese Individuals
    Vibhu Parcha, Nirav Patel, Kiran Musunuru, Kenneth B. Margulies, Thomas P. Cappola, Ganesh V. Halade, Thomas J. Wang, Garima Arora, Pankaj Kumar Arora · 2021 · Journal of the American College of Cardiology
  20. Comparison of the Cardiac Markers B-type Natriuretic Peptide and N-terminal Pro B-type Natriuretic Peptide
    Stefan Büchner, Carsten Gerald Jungbauer, Christoph M. Birner, Kurt Debl, Günter A.J. Riegger, Andreas Luchner · 2009 · Biomarkers in Medicine
  21. Prognostic Accuracy of B-Natriuretic Peptide Measurements and Coronary Artery Calcium in Asymptomatic Subjects (from the Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research [EISNER] Study)
    Leslee J. Shaw, Donna M. Polk, Torry A. Kahute, Nathan D. Wong, Joanna Moon, Romalisa Miranda-Peats, Alan Rozanski, John D. Friedman, Sean W. Hayes, Louise Thomson et al. · 2009 · The American Journal of Cardiology
  22. Gender-specific risk stratification with plasma B-type natriuretic peptide for future onset of congestive heart failure and mortality in the Japanese general population
    Motoyuki Nakamura, Fumitaka Tanaka, Toshiyuki Onoda, Tomohiro Takahashi, Masafumi Sakuma, Kazuko Kawamura, Kozo Tanno, Makaski Ohsawa, Kazuyoshi Itai, Kiyomi Sakata et al. · 2009 · International Journal of Cardiology
  23. Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population
    Valentina Cannone, Alessia Buglioni, S. Jeson Sangaralingham, Christopher G. Scott, Kent R. Bailey, Richard J. Rodeheffer, Margaret M. Redfield, Riccardo Sarzani, John C. Jr Burnett · 2018 · Mayo Clinic Proceedings
  24. Brain Natriuretic Peptide: Diagnostic and Therapeutic Implications in Pulmonary Arterial Hypertension
    Charles William Hargett, Victor F. Tapson · 2005 · Seminars in Respiratory and Critical Care Medicine
  25. Unexpected BNP levels in patients with advanced heart failure: A tale of caution and promise
    Mark H. Drazner, James A. de Lemos · 2005 · American Heart Journal
  26. Left ventricular cavity area reflects N-terminal pro-brain natriuretic peptide plasma levels in heart failure☆
    Raquel Taléns‐Visconti, Miguel Rivera-Otero, M SANCHOTELLO, F DEBURGOS, Luis Martínez‐Dolz, B. Sevilla, Vicente E Climent, Raquel Cortés, A SALVADOR, Francisco Sogorb · 2005 · European Journal of Echocardiography
  27. Regulation of circulating chromogranin B levels in heart failure
    Felix Matthias Heidrich, Carolin Melz, Mimi S. Buechau, Christian Pfluecke, Silvio Quick, Uwe Speiser, David M. Poitz, Antje Augstein, Tobias Friedrich Ruf, Nadine K. Wäßnig et al. · 2017 · Biomarkers
  28. Racial and ethnic differences in circulating N-terminal pro-brain-type natriuretic peptide (NT-proBNP) in US adults
    Yvonne Y Commodore-Mensah, Dan Wang, Yein Jeon, Kathryn E. Foti, John William McEvoy, Josef Coresh, Olive Tang, Justin Basile Echouffo-Tcheugui, Robert H. Christenson, Chiadi E. Ndumele et al. · 2023 · American Journal of Preventive Cardiology
  29. MANP in Hypertension With Metabolic Syndrome
    Xiao Ma, Paul M. McKie, Seethalakshmi R. Iyer, Christopher Scott, Kent R. Bailey, Bradley K. Johnson, Sherry L. Benike, Horng H. Chen, Wayne L. Miller, Aderville Cabassi et al. · 2023 · JACC Basic to Translational Science
  30. Biomarkers in Heart Failure with Preserved Ejection Fraction: A Perpetually Evolving Frontier
    Ana-Maria Vrabie, Stefan Totolici, Caterina Delcea, Elisabeta Bădilă · 2024 · Journal of Clinical Medicine
  31. 2023 Update of the Japanese Heart Failure Society Scientific Statement on BNP and NT-proBNP Levels in Heart Failure Practice
    Masatoshi Minamisawa, Toshihisa Anzai, Takayuki Inomata, Koichiro Kinugawa, Yasushi Sakata, Naoki Sato, Hiroyuki Tsutsui, Kazuhiro Yamamoto, Michihiro Yoshimura, Yoshihiko Saito et al. · 2025 · Journal of Cardiac Failure
  32. Impact of Metabolic Dysfunction–associated Steatotic Liver Disease on Cardiovascular Structure, Function, and the Risk of Heart Failure
    Bhavik Bansal, Fannie Lajeunesse‐Trempe, Neil Keshvani, Carl J. Lavie, Ambarish Pandey · 2025 · Canadian Journal of Cardiology
  33. Active B-Type Natriuretic Peptide Measured by Mass Spectrometry and Response to Sacubitril/Valsartan
    Erica Dillon, Shouzuo D. Wei, Deepak K. Gupta, Hui Nian, Brooks S. Rodibaugh, Katherine N. Bachmann, Allen J. Naftilan, Lynne Warner Stevenson, Nancy Jeanne Brown · 2021 · Journal of Cardiac Failure
  34. Exogenous ANP Treatment Ameliorates Myocardial Insulin Resistance and Protects against Ischemia–Reperfusion Injury in Diet-Induced Obesity
    Yuhei Oi, Tomohisa Nagoshi, Haruka Kimura, Yoshiro Tanaka, Akira Yoshii, Rei Yasutake, H Takahashi, Yusuke Kashiwagi, Toshikazu D. Tanaka, Toshiaki Tachibana et al. · 2022 · International Journal of Molecular Sciences
  35. From Beats to Metabolism: the Heart at the Core of Interorgan Metabolic Cross Talk
    Rafael Romero-Becerra, Ayelén Melina Santamans, Alba C. Arcones, Guadalupe Sabio · 2023 · Physiology
  36. Sex-Specific Threshold Levels of Plasma B-Type Natriuretic Peptide for Prediction of Cardiovascular Event Risk in a Japanese Population Initially Free of Cardiovascular Disease
    Motoyuki Nakamura, Fumitaka Tanaka, Tomohiro Takahashi, Shinji Makita, Takenori Ishisone, Masayuki Onodera, Yasuhiro Ishibashi, Kazuyoshi Itai, Toshiyuki Onoda, Masaki Ohsawa et al. · 2011 · The American Journal of Cardiology
  37. Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy
    Speranza Rubattu, Antonio Barbato, Simona Marchitti, Roberto Iacone, Sara Di Castro, Anna Evangelista, Rosita Stanzione, Renato Ippolito, Sebastiano Sciarretta, Luigi Palmieri et al. · 2010 · Journal of Hypertension
  38. Effect of Obesity on B-Type Natriuretic Peptide Levels in Patients With Pulmonary Arterial Hypertension
    Omar Batal, Michael D. Faulx, Richard A. Krasuski, Omar F. Khatib, Jeffery P. Hammel, Ayman Ali Hussein, Omar A. Minai, Raed A. Dweik · 2012 · The American Journal of Cardiology
  39. Association between sleep-disordered breathing, aminoterminal pro-brain natriuretic peptide (NT-proBNP) levels and insulin resistance in morbidly obese young women
    Juan Ybarra, Francesc Planas, Francesc Navarro-López, Sandra Pujadas, Jaume Pujadas, Jeroni Jurado, José María Pou · 2008 · European Journal of Internal Medicine
  40. Higher BNP levels within physiological range correlate with beneficial nonfasting lipid profiles in the elderly: a cross-sectional study
    Wentao He, Masayuki Mori, Xuefeng Yu, Tsugiyasu Kanda · 2016 · Lipids in Health and Disease
  41. Beneficial Effects of Combined AT 1 Receptor/Neprilysin Inhibition (ARNI) Versus AT 1 Receptor Blockade Alone in the Diabetic Eye
    Tuhina Prasad, Lodi C.W. Roksnoer, Ping Zhu, Amrisha Verma, Yiming Li, Wendy W. Batenburg, René DE VRIES, A.H. Jan Danser, Qiuhong Li · 2016 · Investigative Ophthalmology & Visual Science
  42. Deficient serum furin predicts risk of abdominal obesity: findings from a prospective cohort of Chinese adults
    Yan He, Liyun Ren, Qiu Zhang, Mingzhi Zhang, Jijun Shi, Weidong Hu, Hao Yang Peng · 2020 · Postgraduate Medical Journal
  43. CAN MEASUREMENT OF B‐TYPE NATRIURETIC PEPTIDE LEVELS IMPROVE CARDIOVASCULAR DISEASE PREVENTION?
    Duncan John Campbell · 2008 · Clinical and Experimental Pharmacology and Physiology
  44. The use of B-type natriuretic peptide in the management of patients with atrial fibrillation and dyspnea
    Tobias Breidthardt, Markus Noveanu, Sevgi Cayir, Martina Viglino, Kirsten Laule, Willibald Hochholzer, Tobias Reichlin, Mihael Potocki, Michael Christ, Christian Eugen Mueller · 2008 · International Journal of Cardiology
  45. Mineralocorticoid receptor antagonists and heart failure with preserved ejection fraction: current understanding and future prospects
    Xi Chen, Meinv Huang, Yi Chen, Haishan Xu, Meifang Wu · 2024 · Heart Failure Reviews
  46. N-Terminal Pro-B-type Natriuretic Peptide Levels in the Korean General Population
    Kyung-Hoon Lee, Jang‐Young Kim, Sang Baek Koh, Seung‐Hwan Lee, Junghan Yoon, Sang-Woo Han, Jong-Ku Park, Kyung‐Hoon Choe, Byung‐Su Yoo · 2010 · Korean Circulation Journal
  47. Brain Natriuretic Peptide in Plasma as Predictor of All-Cause Mortality in a Large Danish Primary Health Care Population Suspected of Heart Failure
    J Hejl, Mia Klinten Grand, Volkert Siersma, Jens Peter Goetze, Niels de Fine Olivarius, Christen Lykkegaard Andersen, Bent Lind · 2018 · Clinical Chemistry
  48. Soluble ST2 in Ventricular Dysfunction
    Silvia Lupu, Lucia Agoşton-Coldea · 2015 · Advances in clinical chemistry
  49. Incidence of atrial and ventricular arrhythmias in obese patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
    Mohammad Abumayyaleh, Jonathan Demmer, Carina Krack, Christina Pilsinger, Ibrahim El‐Battrawy, Assem Aweimer, Siegfried Lang, Andreas Mügge, İbrahim Akın · 2023 · Diabetes Obesity and Metabolism
  50. HFpEF: New biomarkers and their diagnostic and prognostic value
    Shahanaz parveen Shaik, Hasnain hyder Karan, Arkaja Singh, Sai kiran Attuluri, Afnan Akram Nawaz Khan, Fazila Zahid, Dhrumil Patil · 2023 · Current Problems in Cardiology
  51. Exploring the Mechanistic Link Between Obesity and Heart Failure
    Bige Özkan, Chiadi E. Ndumele · 2023 · Current Diabetes Reports
  52. Identifying Biomarker Patterns and Predictors of Inflammation and Myocardial Stress
    Ruth Masterson Creber, C S Lee, Kenneth B. Margulies, Barbara J. Riegel · 2015 · Journal of Cardiac Failure
  53. New biomarkers and heart failure
    Dagmar Vondráková, Filip Málek, Petr Ošťádal, Andreas Krüger, Petr Neužil · 2013 · Cor et Vasa
  54. Impact of underlying heart disease per se on the utility of preoperative NT-proBNP in adult cardiac surgery
    Huiqi Jiang, Henrik Hultkvist, Jonas Holm, Farkas B. Vánky, Yanqi Yang, Rolf Svedjeholm · 2018 · PLoS ONE
  55. Homeostasis Model Assessment of Insulin Resistance and Survival in Patients With Diabetes and Acute Coronary Syndrome
    Barbara Elisabeth Stähli, Anna Nozza, Ilse C. Schrieks, John B. Buse, Klas Malmberg, Linda Mellbin, Bruce Charles Neal, Stephen James Nicholls, Lars Rydén, Anders Svensson et al. · 2018 · The Journal of Clinical Endocrinology & Metabolism
  56. Morbid Obesity as a Therapeutic Target for Heart Failure
    Chonyang Lu Albert · 2019 · Current Treatment Options in Cardiovascular Medicine
  57. The Influence of Body Mass Index on Clinical Interpretation of Established and Novel Biomarkers in Acute Heart Failure
    Yu Horiuchi, Nicholas W. Wettersten, DIRK J. VANVELDHUISEN, Christian Eugen Mueller, Richard M. Nowak, Christopher J. Hogan, Michael Christopher Kontos, Chad M Cannon, Robert Birkhahn, Gary M. Vilke et al. · 2023 · Journal of Cardiac Failure
  58. Deletion of the Npr3 gene increases severity of acute lung injury in obese mice
    Brianna D. Guarino, Christopher Dado, Ashok Kumar, Julie Braza, Elizabeth O. Harrington, James R. Klinger · 2023 · Pulmonary Circulation
  59. Regulation of B‐type natriuretic peptide synthesis by insulin in obesity in male mice
    Haihua Zhang, Robrecht Thoonen, Vincent Yao, Emmanuel S. Buys, John Popovich, Yan Ru Su, Thomas J. Wang, Marielle Scherrer‐Crosbie · 2015 · Experimental Physiology
  60. N-terminal pro-brain natriuretic peptide in cases with metabolic syndrome and its relationship with components of metabolic syndrome and left ventricular mass index
    Yusuf Sezen, Memduh Baş, Recep Demirbağ, Ali Yıldız, Hakim Çelık, Şahin Aksoy · 2009 · Clinical Biochemistry
  61. A genetic variant of the atrial natriuretic peptide gene is associated with left ventricular hypertrophy in a non-diabetic population – the Malmö preventive project study
    Amra Jujić, Margrét Leósdóttir, Gerd Östling, Petri Gudmundsson, Peter M. Nilsson, Olle Melander, Martin Magnusson · 2013 · BMC Medical Genetics
  62. N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity
    Fábio Fernandes, Félix José Alvarez Ramires, Paula C. Buck, I.J. Almeida, Rogério Rabelo, Simone Alves Dantas, Vera Maria Cury Salemi, Alfredo Halpern, Charles Mady · 2007 · Brazilian Journal of Medical and Biological Research
  63. The influence of body composition on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with acute coronary syndrome: a cohort study
    Fang‐Yang Huang, Hua Wang, Bao‐Tao Huang, Wei Liu, Yong Peng, Chen Zhang, Tianli Xia, Pengju Wang, Zhi‐Liang Zuo, Yue Heng et al. · 2016 · Cardiovascular Diabetology
  64. Exploring The Obesity Paradox In Atrial Fibrillation. AFBAR (Atrial Fibrillation Barbanza Area) Registry Results.
    María Cristina González-Cambeiro, Emad Abu‐Assi, Sergio Raposeiras‐Roubín, Moisés Rodríguez‐Mañero, Fernando Otero-Raviña, José Ramón González‐Juanatey, Genaro Gutiérrez-Fernández, Rosa Liñares-Stolle, Jorge Alvear-García, Ma Jesús Eirís-Cambre et al. · 2014 · Europe PMC (PubMed Central)
  65. Predictors of 10-year changes in levels of N-terminal pro B-type natriuretic peptide and cardiac troponin I in the elderly
    Kai M. Eggers, Bertil Lindahl, Per Venge, Lars Lind · 2018 · International Journal of Cardiology
  66. Body mass index and all-cause mortality in patients with atrial fibrillation: insights from the China atrial fibrillation registry study
    Lu Wang, Xin Du, Jianzeng Dong, Wen-Na Liu, Yingchun Zhou, Songnan Li, Xueyuan Guo, Chenxi Jiang, Ronghui Yu, Caihua Sang et al. · 2019 · Clinical Research in Cardiology
  67. Biochemical markers after the Norseman Extreme Triathlon
    Christoffer Nyborg, Jørgen Melau, Martin Bonnevie-Svendsen, Maria Mathiasen, Helene Støle Melsom, Andreas Berg Storsve, Jonny Hisdal · 2020 · PLoS ONE
  68. BNP for Clinical Monitoring of Heart Failure
    Richard William Troughton, Mark Richards · 2006 · Heart Failure Clinics
  69. Poor Masticatory Capacity and Blood Biomarkers of Elevated Cardiovascular Disease Risk in the Community: The Paris Prospective Study III
    Eirini Chatzopoulou, Hélène Rangé, Omar Deraz, Pierre Boutouyrie, Marie‐Cécile Perier, Catherine Guibout, Frédérique Thomas, Muriel Andrieu, Karine Bailly, Benoı̂t Vedie et al. · 2021 · Arteriosclerosis Thrombosis and Vascular Biology
  70. Association between Intra- and Extra-Cellular Water Ratio Imbalance and Natriuretic Peptides in Patients Undergoing Hemodialysis
    Yui Nakayama, Yosuke Yamada, Shingo Ishii, Mai Hitaka, Keisuke Yamazaki, Motoyuki Masai, Nobuhiko Joki, Ken Sakai, Yasushi Ohashi · 2023 · Nutrients
  71. Differential cardiopulmonary haemodynamic phenotypes in PASC-related exercise intolerance
    Peter A. Kahn, Phillip Joseph, Paul M. Heerdt, Inderjit Singh · 2023 · ERJ Open Research
  72. N-Terminal Pro-B-Type Natriuretic Peptide Is Inversely Associated With Metabolic Syndrome in Hypertensive Patients
    Huai-Ren Chang, Jen‐Che Hsieh, Michael Yu‐Chih Chen, Ji-Hung Wang, Bang‐Gee Hsu, Huai-Ren Chang, Michael Yu‐Chih Chen, Bang‐Gee Hsu, Ji‐Hung Wang, Ling-Yi Wang · 2014 · The American Journal of the Medical Sciences
  73. Plasma B-type natriuretic peptide is a useful tool for assessing coronary heart disease risk in a Japanese general population
    Takuya Hasegawa, Masanori Asakura, Kazuo Eguchi, Hiroshi Asanuma, Takahiro Ohara, Hideaki Kanzaki, Kazuhiko Hashimura, Hitonobu Tomoike, Jiyoong Kim, Masafumi Kitakaze · 2014 · Hypertension Research
  74. Homoarginine—A prognostic indicator in adolescents and adults with complex congenital heart disease?
    Tanja M. Raedle-Hurst, Marieke Mueller, Andreas Meinitzer, Winfried Maerz, Thomas Bernd Dschietzig · 2017 · PLoS ONE
  75. Expert consensus on the usefulness of natriuretic peptides in heart failure
    Jadwiga Maria Nessler, Ewa Straburzyńska‐Migaj, Adam Windak, Bogdan Solnica, Maciej Szmitkowski, Marek T Paradowski, Jarosław Kaźmierczak, Elżbieta Puacz, Piotr Rozentryt · 2018 · Kardiologia Polska
  76. Post-discharge rise in BNP and rehospitalization for heart failure
    Hesham Rashad Omar, Maya E. Guglin · 2018 · Herz
  77. Glycosylation of natriuretic peptides in obese heart failure: mechanistic insights
    Vibhu Parcha, Pankaj Kumar Arora · 2019 · Annals of Translational Medicine
  78. Gender‐specific association between body mass index and all‐cause mortality in patients with atrial fibrillation
    Si‐qi Lyu, Yanmin Yang, Jun Zhu, Juan Wang, Shuang Wu, Han Zhang, Xing‐hui Shao, Jiameng Ren · 2020 · Clinical Cardiology
  79. Factors Associated with Baseline and Serial Changes in Circulating Nt-Probnp and High-Sensitivity Cardiac Troponin T in A Population-Based Cohort (Dallas Heart Study)
    Christopher W Puleo, Colby R. Ayers, Sonia Garg, Ian J. Neeland, Alana Lewis, Ambarish Pandey, Mark H. Drazner, James A. de Lemos · 2021 · Biomarkers in Medicine
  80. Serum atrial natriuretic peptide level inversely associates with metabolic syndrome in older adults
    Ji‐Hung Wang, Chung‐Jen Lee, Jen‐Che Hsieh, Yu‐Chih Chen, Bang‐Gee Hsu · 2013 · Geriatrics and gerontology international/Geriatrics & gerontology international
  81. Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment?
    J.M. Peeters, Sandra Sanders‐van Wijk, S. Bektas, Christian Knackstedt, Peter R. Rickenbacher, Fabian Nietlispach, Rolf Handschin, Micha Tobias Maeder, Stefano Muzzarelli, Matthias Emil Pfisterer et al. · 2013 · Netherlands Heart Journal
  82. Value of brain natriuretic peptides in primary care patients with the clinical diagnosis of chronic heart failure
    Michel Züber, Florim Cuculi, Christine H. Attenhofer Jost, Peter Kipfer, Peter T. Buser, Burkhardt Seifert, Paul Erné · 2009 · Scandinavian Cardiovascular Journal
  83. Hyperinsulinemia correlates with low levels of plasma B-type natriuretic peptide in Japanese men irrespective of fat distribution
    Hideaki Nakatsuji, Ken Kishida, Tohru Funahashi, Tohru Nakagawa, Iichiro Shimomura · 2012 · Cardiovascular Diabetology
  84. Inverse Correlation of Venous Brain Natriuretic Peptide Levels with Body Mass Index Is due to Decreased Production
    Zubair I. Shah, Mark A Wiley, Arun Mahankali Sridhar, Reza Masoomi, Mazda Biria, Dhananjay Lakkireddy, Buddhadeb Dawn, Kamal Gupta · 2017 · Cardiology
  85. The relationship between tissue Doppler imaging and seric NTproBNP levels in sinus rhythm patients: a prospective study
    Cristian Mornoş, Adina Ionac, Dragoș Constantin Cozma, Dan Ruşinaru, Daniela Maximov, Lucian Petrescu, Maria Alina Lupu, Stefan-Iosif Dragulescu · 2007 · International journal of cardiac imaging
  86. Phosphodiesterase 5 Inhibitor Ameliorates Renal Resistance to Atrial Natriuretic Peptide Associated with Obesity and Hyperleptinemia
    Jerzy Bełtowski, Anna Jamróz-Wiśniewska, Ewelina Borkowska, Andrzej Marciniak · 2006 · Archives of Medical Research
  87. Obese and Nonobese Patients With Essential Hypertension Show Similar N-terminal proBNP Plasma Levels
    Raquel Cortés, Miguel Rivera Otero, Pedro Morillas, Esther Roselló‐Lletí, Lilian Grigorian, Luis Martínez‐Dolz, Fernando Garcı́a de Burgos, Jose Ramon Calabuig, F. Soria, Teresa Lozano et al. · 2008 · American Journal of Hypertension
  88. Natriuretic Peptides, Body Mass Index, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
    John W. Ostrominski, Brendon Lange Neuen, Brian Lee Claggett, Inder S. Anand, Akshay Suvas Desai, Pardeep S. Jhund, Carolyn S.P. Lam, Marc Alan Pfeffer, Bertram Pitt, Faiez M. Zannad et al. · 2025 · Journal of the American College of Cardiology
  89. Do Most Obese People with Exercise Intolerance and a Normal Ejection Fraction Have Treatable Heart Failure?
    Milton Packer · 2018 · The American Journal of Medicine
  90. Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61
    Siddharth M. Patel, David A. Morrow, Andrea Bellavia, David D. Berg, Deepak L. Bhatt, Petr Jarolı́m, Lawrence A. Leiter, Darren K. McGuire, Itamar Raz, Philippe Gabríel Steg et al. · 2023 · European Journal of Heart Failure
  91. Obesity as an independent risk for left ventricular diastolic dysfunction in 692 Japanese patients
    Kinuko Dote, Yoko Miyasaka, Satoshi Tsujimoto, Masayuki Motohiro, Hirofumi Maeba, Yoshinobu Suwa, Toshiji Iwasaka · 2012 · Obesity Research & Clinical Practice
  92. Determinants of N-Terminal Pro-Brain Natriuretic Peptide Variation in Hemodialysis Patients and Prediction of Survival
    Sunna Snaedal, Abdul Rashid Qureshi, Juan Jesús Carrero, Olof Heimbürger, Peter Stenvinkel, Peter F. Barany · 2014 · Blood Purification
  93. Impact of Body Mass Index on Plasma N-Terminal ProB-Type Natriuretic Peptides in Chinese Atrial Fibrillation Patients without Heart Failure
    Lihui Zheng, Lingmin Wu, Yan Yao, Wensheng Chen, Jingru Bao, Wen Huang, Rui Shi, Kuijun Zhang, Shu Zhang · 2014 · PLoS ONE
  94. Effects of chronic elevation of atrial natriuretic peptide and free fatty acid levels in the induction of type 2 diabetes mellitus and insulin resistance in patients with mitral valve disease
    Lorenzo Monti, Pietro Lucotti, Emanuela Setola, Alessandra Rossodivita, Maria Grazia Pala, Elena Galluccio, Giovanni La Canna, Alessandro Castiglioni, Marianna Cannoletta, C. Meloni et al. · 2010 · Nutrition Metabolism and Cardiovascular Diseases
  95. Impact of alcohol intake on the relationships of uric acid with blood pressure and cardiac hypertrophy in essential hypertension
    Shingo Seki, Yoshitsugu Oki, Seiko Tsunoda, Tomoyuki Takemoto, Tatsuya Koyama, Michihiro Yoshimura · 2015 · Journal of Cardiology
  96. Association between N-terminal pro-brain natriuretic peptide and adiponectin in healthy Japanese men
    Kaori Nakanishi, Makoto Nishida, Ryohei Yamamoto, Masahiro Koseki, Toshiki Moriyama, Keiko Yamauchi‐Takihara · 2016 · Clinica Chimica Acta
  97. Impact of body mass index on mortality and hospitalisation of patients with atrial fibrillation
    Jocasta Ball, Maja‐Lisa Løchen, Melinda Jane Carrington, Joshua F. Wiley, Simon Stewart · 2018 · European Journal of Cardiovascular Nursing
  98. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study
    Freja Gaborit, Caroline Kistorp, Thomas Kümler, Christian Hassager, Niels Tønder, Kasper Karmark Iversen, Pernille Mørk Hansen, Pia R. Kamstrup, Jens Oscar Faber, Lars Køber et al. · 2020 · Biomarkers
  99. Role of natriuretic peptides in the cardiovascular-adipose communication: a tale of two organs
    Natalia L. Rukavina Mikusic, Nicolás Martín Kouyoumdzian, Ana M. Puyó, Belisario Enrique Fernández, Marcelo R. Choi · 2021 · Pflügers Archiv - European Journal of Physiology
  100. Transient Receptor Potential Channels, Natriuretic Peptides, and Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure
    Kun Ding, Yang Gui, Xu Hou, Lifang Ye, Lihong Wang · 2022 · Frontiers in Cardiovascular Medicine